These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 3470595

  • 1. [CA-19-9, CA50 and CEA in pancreatic and gastrointestinal tumors. Comparative studies].
    Dienst C, Clodius T, Oldörp T, Uhlenbruck G, Diehl V.
    Med Klin (Munich); 1987 Jan 30; 82(2):45-50. PubMed ID: 3470595
    [No Abstract] [Full Text] [Related]

  • 2. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
    Klapdor R, Greten H.
    Dtsch Med Wochenschr; 1984 Dec 14; 109(50):1935-9. PubMed ID: 6210188
    [No Abstract] [Full Text] [Related]

  • 3. Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) in pancreatic cancer. Role of age and liver dysfunction.
    Del Favero G, Fabris C, Panucci A, Basso D, Plebani M, Baccaglini U, Leandro G, Burlina A, Naccarato R.
    Bull Cancer; 1986 Dec 14; 73(3):251-5. PubMed ID: 3530354
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Ganglioside and carcinoembryonic antigens in the diagnosis of malignant tumors of the gastrointestinal tract].
    Ivanov PK, Samoĭlenko VM.
    Vopr Onkol; 1984 Dec 14; 30(9):55-9. PubMed ID: 6495695
    [Abstract] [Full Text] [Related]

  • 6. Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
    Mennini G, Silecchia G, Zanna C, Cucchiara G, Spadaro G, Greco E, Basoli A, Speranza V.
    Ital J Surg Sci; 1985 Dec 14; 15(1):37-43. PubMed ID: 3858272
    [Abstract] [Full Text] [Related]

  • 7. [CA-50: evaluation of a new tumor marker in the diagnosis of neoplastic pathologies of the gastrointestinal tract].
    Pecchio F, Ricci E, Rapellino M, Oliaro A, Adamo MR, Marzola G, Piantino P.
    Minerva Med; 1987 Feb 15; 78(3):141-4. PubMed ID: 3469541
    [Abstract] [Full Text] [Related]

  • 8. Levels of carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) in sera and pancreatic juice in the diagnosis of pancreatic cancer.
    Lin JT, Wang TH, Chen DS, Sung JL.
    Taiwan Yi Xue Hui Za Zhi; 1987 Aug 15; 86(8):823-8. PubMed ID: 3479516
    [No Abstract] [Full Text] [Related]

  • 9. Serum CA 19-9 and CA 50 antigens in hemodialysis patients.
    Docci D, Pistocchi E, Turci F, Baldrati L, Urbini S, Scaioli S.
    Clin Nephrol; 1987 Apr 15; 27(4):179-81. PubMed ID: 3472698
    [Abstract] [Full Text] [Related]

  • 10. The combined use of CA 19-9 and carcino-embryonic antigen (CEA) in malignancies of the gastrointestinal tract.
    Staab HJ.
    Acta Gastroenterol Belg; 1987 Apr 15; 50(1):29-35. PubMed ID: 3480668
    [No Abstract] [Full Text] [Related]

  • 11. [Occurrence of pancreatic tumor markers and diagnosis of small pancreatic tumors. 7). Usefulness of combination assay].
    Niitsu Y, Kohda K.
    Nihon Rinsho; 1986 Aug 15; 44(8):1843-7. PubMed ID: 3537376
    [No Abstract] [Full Text] [Related]

  • 12. [New monoclonal antibodies in the diagnosis of gastrointestinal cancers].
    Heptner G, Domschke S, Domschke W.
    Internist (Berl); 1986 Nov 15; 27(11):723-8. PubMed ID: 2433247
    [No Abstract] [Full Text] [Related]

  • 13. [Diagnosis of tumors with the use of immunologic tumor markers].
    Vorlaender KO.
    Wien Med Wochenschr; 1983 Feb 15; 133(3):59-66. PubMed ID: 6189301
    [No Abstract] [Full Text] [Related]

  • 14. [Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers].
    Capocasale E, Contini S, Rossetti A, Del Sante G, Gregori G.
    Acta Biomed Ateneo Parmense; 1985 Feb 15; 56(6):231-6. PubMed ID: 2940782
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Comparison of the T.A.T.I. marker with CEA and Ca 19-9 in neoplasms of the gastrointestinal system. Preliminary data].
    Ricci E, Pecchio F, Rapellino M, Giaccone M, Adamo R, Boltri F, Oliaro A.
    Minerva Dietol Gastroenterol; 1988 Feb 15; 34(4):217-20. PubMed ID: 3247053
    [No Abstract] [Full Text] [Related]

  • 19. [Serial changes in serum CA 19-9 levels in pancreatic cancer].
    Saito K, Tajiri H, Yoshimori M, Hijikata A, Ohkura H, Nakamura K, Ozaki H.
    Gan No Rinsho; 1987 Aug 15; 33(9):1057-60. PubMed ID: 3476762
    [Abstract] [Full Text] [Related]

  • 20. [Antigens associated with cancer of the pancreas].
    Burtin P.
    Bull Cancer; 1990 Aug 15; 77(1):69-73. PubMed ID: 2317577
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.